metformin is a drug used in humans for type ii diabetes, and has been shown to improve insulin sensitivity and reduce output of glucose by the liver. however, it has low bioavailability in horses, and does not appear to affect insulin sensitivity at doses that are commonly used. its current mechanism of action in horses is thought to be a reduction in intestinal glucose absorption, and therefore postprandial glucose levels, when it is given before meals.